PL BioScience Unveils Groundbreaking Artificial Human Platelet Lysate at ISCT Conference
Aachen, Germany – May 8, 2025 – In a pioneering move within biotechnology, PL BioScience GmbH has announced the first-ever artificial Human Platelet Lysate (HPL) solution, a significant leap forward for cell-based pharmaceuticals. This innovative development, made possible through a collaboration with South Korea’s DewCell Biotherapeutics, utilizes a proprietary method to transform lab-grown platelets into a scalable cell culture supplement.
Addressing the pressing need for sustainable and ethical options in cell culture, the artificial HPL presents a cutting-edge alternative to traditional Fetal Bovine Serum (FBS) and conventional donor-derived natural HPL, known for its limitations in supply. The enhanced production process results in a product that not only matches but exceeds the performance of existing cell culture supplements, while boasting improved safety and consistency.
Dr. Hatim Hemeda, CEO of PL BioScience, expressed confidence in the transformative potential of this breakthrough. "Cell culture innovation is crucial for advancing modern medicine and drug discovery," he stated, emphasizing the capability for nearly unlimited supply, aligning with the booming biopharmaceutical industry.
The launch is set against the backdrop of the International Society for Cell & Gene Therapy (ISCT) conference in New Orleans, where Dr. Hemeda will present the new technology at 6:15 PM CDT, underlining its role in promoting xeno-free solutions for cell therapies.
PL BioScience’s ELAREM™ line, which includes both natural and now synthetic HPL products, supports the growth and expansion of cells in research and therapeutic settings, marking a significant step forward in regenerative medicine.
For more information about PL BioScience and its innovative products, visit PL BioScience.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
